PMC:7299399 / 28035-28235 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T270","span":{"begin":63,"end":69},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T271","span":{"begin":187,"end":190},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"ments specifically to select candidate materials that might be tested for clinical implementation as vaccine adjuvants.90\nIn this view, the status of nanomaterial-based vaccine adjuvants has been revi"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T209","span":{"begin":109,"end":118},"obj":"Chemical"},{"id":"T210","span":{"begin":177,"end":186},"obj":"Chemical"}],"attributes":[{"id":"A209","pred":"chebi_id","subj":"T209","obj":"http://purl.obolibrary.org/obo/CHEBI_60809"},{"id":"A210","pred":"chebi_id","subj":"T210","obj":"http://purl.obolibrary.org/obo/CHEBI_60809"}],"text":"ments specifically to select candidate materials that might be tested for clinical implementation as vaccine adjuvants.90\nIn this view, the status of nanomaterial-based vaccine adjuvants has been revi"}

{"project":"2_test","denotations":[{"id":"32519842-26791076-158516","span":{"begin":119,"end":121},"obj":"26791076"}],"text":"ments specifically to select candidate materials that might be tested for clinical implementation as vaccine adjuvants.90\nIn this view, the status of nanomaterial-based vaccine adjuvants has been revi"}